TB500 vs Thymosin Beta 4

About this video

Niddam and CanLabs founder Jean-François Tremblay untangle a persistent naming confusion: TB-500 versus thymosin beta-4. Tremblay explains that TB-500 is a short fragment of the much longer thymosin beta-4 protein, and that different fragments of the parent molecule are associated in his account with different activities, from tissue repair to anti-fibrotic effects. He argues the full-length molecule offers broader actions, including on nerves and immune regulation, while the fragment is narrower and more cost-efficient for targeted musculoskeletal repair. The conversation widens into how peptide fragments get isolated and marketed, and how to read research critically, since abstracts can oversell narrow, early findings.

Key takeaways

• Check a peptide’s amino-acid chain length to know whether a source means the fragment or the full molecule
• Tremblay presents the fragment as narrower and cheaper, the full molecule as broader in claimed effects
• Names are used interchangeably by sellers and even educators, so verify what is actually in the vial
• Read past study abstracts; early proof-of-concept results are not definitive answers
• Balance published research against long clinical experience rather than treating either as final

Episode details: published November 3, 2019 · 6.5K views · 33:23 long. Summary written by Self Growth Videos from the episode itself. The longevity and peptide concepts described are Nathalie Niddam’s or her guests’, presented for education — not medical advice. Consult a qualified professional before changing your own health practices. Disclosure: Niddam promotes peptide products through affiliate arrangements with peptide vendors, a commercial conflict; Self Growth Videos reproduces none of her codes.

← Previous: Peptides For Immune Modulation: Thymulin vs Thymalin with Jean-Francois Tremblay from CanLabs · Next: Peptides for Cognitive Performance →

All Nathalie Niddam videos · Nathalie Niddam profile · Nathalie Niddam (official site)